1. Home
  2. FSBW vs SCPH Comparison

FSBW vs SCPH Comparison

Compare FSBW & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • SCPH
  • Stock Information
  • Founded
  • FSBW 1936
  • SCPH 2013
  • Country
  • FSBW United States
  • SCPH United States
  • Employees
  • FSBW N/A
  • SCPH N/A
  • Industry
  • FSBW Banks
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • SCPH Health Care
  • Exchange
  • FSBW Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • FSBW 308.6M
  • SCPH 299.0M
  • IPO Year
  • FSBW 2012
  • SCPH 2017
  • Fundamental
  • Price
  • FSBW $40.04
  • SCPH $5.67
  • Analyst Decision
  • FSBW Hold
  • SCPH Buy
  • Analyst Count
  • FSBW 1
  • SCPH 3
  • Target Price
  • FSBW $44.00
  • SCPH $12.00
  • AVG Volume (30 Days)
  • FSBW 18.5K
  • SCPH 1.5M
  • Earning Date
  • FSBW 10-21-2025
  • SCPH 11-12-2025
  • Dividend Yield
  • FSBW 2.80%
  • SCPH N/A
  • EPS Growth
  • FSBW N/A
  • SCPH N/A
  • EPS
  • FSBW 4.15
  • SCPH N/A
  • Revenue
  • FSBW $139,676,000.00
  • SCPH $49,969,000.00
  • Revenue This Year
  • FSBW $9.62
  • SCPH $104.30
  • Revenue Next Year
  • FSBW $5.35
  • SCPH $76.06
  • P/E Ratio
  • FSBW $9.64
  • SCPH N/A
  • Revenue Growth
  • FSBW 0.61
  • SCPH 107.79
  • 52 Week Low
  • FSBW $34.61
  • SCPH $1.94
  • 52 Week High
  • FSBW $49.15
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 43.95
  • SCPH 64.40
  • Support Level
  • FSBW $39.00
  • SCPH $5.64
  • Resistance Level
  • FSBW $40.20
  • SCPH $5.65
  • Average True Range (ATR)
  • FSBW 1.03
  • SCPH 0.03
  • MACD
  • FSBW -0.21
  • SCPH -0.02
  • Stochastic Oscillator
  • FSBW 27.15
  • SCPH 75.00

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: